Dermal disorders such as psoriasis and eczema are associated with modifications in the
chemical and molecular composition of the skin. Clobetasol propionate (CP), a superpotent …

Numerous studies have identified the presence and bioactivity of glucocorticoid receptor
(GR) active substances in water; however, the identification and activity-balance of GR …

Performance and mechanism of non-thermal plasma (NTP) technology in removing
glucocorticoids (GCs) was investigated using a dielectric barrier discharge (DBD) reactor …

In the present study chitin nanogel loaded with anti-psoriatic drug clobetasol was developed
(CLCNG) for its topical delivery in psoriasis. CLCNG had the particle size of 132±14 nm, with …

The aim of this study was to prepare and to evaluate the physicochemical and in vitro drug
release characteristics of different nanostructured systems containing clobetasol propionate …

The solubilities of desoxycorticosterone acetate (DA) and clobetasole propionate (CP) in
supercritical carbon dioxide (SC-CO2) were measured at temperature ranging from (308 to …

Objective (s): A new binary mixture containing mometasone furoate (MF) and calcipotriol
(CP) is suggested to manage psoriasis; since the combined stability profile of these drugs is …

Psoriasis is a chronic immune-mediated skin disorder, induced by aberrant activation of
dendritic cells, followed by modifications in the immune cells (skin) and keratinocytes …

Identification of transformation products and elucidation of degradation pathways of
pharmaceuticals in the environment is a challenging task due to the numerous compounds …

The problem of photostability of drugs has received relatively little attention in the
pharmaceutical industry. Furthermore, until a decade ago, the degradation studies carried …